Clinical Trials
3 trialsNCT05572970 2026-05-06
Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)
Agenus Inc.
Available
NCT06322108 2025-05-08
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
Immune Oncology Research Institute
Phase 2 Recruiting
NCT04156100 2022-03-03
A Study in Subjects With Advanced Solid Tumors
Agenus Inc.
Phase 1 Terminated